Merit Medical Systems Gross Profit 2010-2024 | MMSI

Merit Medical Systems gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Merit Medical Systems Annual Gross Profit
(Millions of US $)
2023 $584
2022 $519
2021 $485
2020 $401
2019 $432
2018 $395
2017 $326
2016 $265
2015 $236
2014 $225
2013 $194
2012 $182
2011 $165
2010 $128
2009 $109
Merit Medical Systems Quarterly Gross Profit
(Millions of US $)
2024-03-31 $152
2023-12-31 $151
2023-09-30 $142
2023-06-30 $153
2023-03-31 $138
2022-12-31 $135
2022-09-30 $129
2022-06-30 $135
2022-03-31 $121
2021-12-31 $129
2021-09-30 $120
2021-06-30 $124
2021-03-31 $112
2020-12-31 $111
2020-09-30 $102
2020-06-30 $84
2020-03-31 $104
2019-12-31 $112
2019-09-30 $104
2019-06-30 $112
2019-03-31 $105
2018-12-31 $105
2018-09-30 $102
2018-06-30 $100
2018-03-31 $88
2017-12-31 $86
2017-09-30 $81
2017-06-30 $84
2017-03-31 $76
2016-12-31 $70
2016-09-30 $68
2016-06-30 $67
2016-03-31 $60
2015-12-31 $60
2015-09-30 $59
2015-06-30 $61
2015-03-31 $55
2014-12-31 $60
2014-09-30 $57
2014-06-30 $56
2014-03-31 $52
2013-12-31 $53
2013-09-30 $51
2013-06-30 $47
2013-03-31 $43
2012-12-31 $45
2012-09-30 $45
2012-06-30 $47
2012-03-31 $44
2011-12-31 $42
2011-09-30 $41
2011-06-30 $42
2011-03-31 $40
2010-12-31 $36
2010-09-30 $31
2010-06-30 $32
2010-03-31 $28
2009-12-31 $27
2009-09-30 $29
2009-06-30 $28
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.726B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00